Table 2.

Association of LUNAR1 and clinical factors with disease-free survival in patients with CRC.

	Unadjusted HR* (95% CI)	P	Adjusted HR† (95% CI)	P
LUNAR1 level	3.25 (1.98–5.31)	<0.001	2.81 (1.69–4.67)	<0.001
Sex	0.92 (0.697–1.40)	0.983	0.91 (0.63–1.32)	0.630
Age	1.24 (0.87–1.77)	0.238	1.03 (0.71–1.49)	0.894
Tumour location	1.11 (0.53–2.32)	0.790	1.18 (0.79–1.77)	0.406
Tumour size	1.82 (0.56–5.95)	0.319	1.50 (0.48–4.67)	0.489
Differentiation status	2.44 (1.45–4.11)	0.001	1.19 (0.36–3.95)	0.780
TNM stage	3.01 (1.60–5.66)	0.001	3.26 (1.71–6.20)	<0.001

*Hazard ratios in univariate models.

^†Hazard ratios in multivariable models.

Abbreviations: HR, hazard ratio; 95% CI, 95% confidence interval.